Detroit Medical Group, PLLC

Detroit Medical Group, PLLC was paid $2.18M by Medicaid between Jan 2018 and Nov 2024, across 73 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.

33Billing provider infoDETROIT MEDICAL GROUP, PLLC
DETROIT, MI 48205

33aNPI1255439956assigned 09/20/2006

33bProvider typeInternal Medicine Physician

28Total paid$2.18M

24GClaims179,749

24DCodes billed73

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Internal Medicine Physician providers in Michigan

Rank by total paid#55 of 816

Median peer was paid$70K

This provider vs. median31×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	46,287	$506K
2019	31,492	$384K
2020	25,234	$326K
2021	24,543	$315K
2022	21,842	$254K
2023	19,428	$246K
2024incomplete	10,923	$144K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	50%	13,089	11,731	$1.10M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	22%	8,278	7,495	$478K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	7.9%	2,198	2,057	$172K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	6.2%	1,503	1,426	$134K
99407		2.4%	3,904	3,654	$53K
99385		1.7%	410	369	$36K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.3%	1,003	868	$29K
81002		<1%	8,646	7,925	$21K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,401	2,160	$20K
81025		<1%	3,089	2,807	$19K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	256	205	$16K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,459	2,203	$14K

61 more codes

Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	726	$13K
99386		<1%	136	$12K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	181	$11K
99441		<1%	276	$9K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,148	$9K
90686		<1%	500	$8K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	84	$6K
92551		<1%	849	$5K
90472	Immunization administration, each additional vaccine (list separately)	<1%	369	$4K
99496		<1%	35	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	13	$2K
82962		<1%	615	$2K
90733		<1%	65	$1K
93000		<1%	145	$992.35
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	37	$877.83
99442		<1%	44	$731.23
86580		<1%	198	$644.69
94010		<1%	37	$589.12
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	34	$261.78
1159F		<1%	12,298	$183.11
96160		<1%	19	$160.00
90649		<1%	93	$155.03
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	16	$148.25
82270		<1%	61	$141.75
1160F		<1%	12,483	$15.55
3074F		<1%	9,021	$6.99
3011F		<1%	6,650	$6.86
3754F		<1%	6,529	$6.03
3511F		<1%	6,002	$5.90
3078F		<1%	7,488	$5.61
4000F		<1%	4,842	$5.30
3016F		<1%	4,787	$5.11
1008F		<1%	5,297	$4.78
3077F		<1%	4,824	$4.73
3080F		<1%	4,007	$4.70
3079F		<1%	4,765	$4.63
3075F		<1%	3,017	$3.65
93770		<1%	817	$1.25
4037F		<1%	475	$1.04
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	8,218	$0.66
3061F		<1%	4,618	$0.63
3725F		<1%	4,866	$0.63
3008F		<1%	8,521	$0.60
3352F		<1%	206	$0.43
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	<1%	24	$0.15
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	24	$0.15
4015F		<1%	182	$0.14
3015F		<1%	495	$0.14
G8473	Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed	<1%	3,835	$0.08
G8450	Beta-blocker therapy prescribed	0%	804	$0.00
4086F		0%	1,175	$0.00
90716		0%	62	$0.00
1038F		0%	88	$0.00
90670		0%	41	$0.00
90707		0%	66	$0.00
4124F		0%	179	$0.00
90687		0%	15	$0.00
90715		0%	16	$0.00
90713		0%	18	$0.00
90700		0%	35	$0.00
90633		0%	42	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAQUE, NAZMUL (OWNER)